Research article · 1 Jun 2017
Research articlePublished 19 Apr 2014
XB130 Expression in Human Osteosarcoma: A Clinical and Experimental Study
1Department of Orthopedics, The central hospital of Yishui, China; 2Department of Orthopedics, the Linyi People’s Hospital, China; 3Department of Pathology, Affiliated Hospital of medical college, Qingdao University, China; 4Department of Anesthesiology, Affiliated Hospital of medical college, Qingdao University, China
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Identifying prognostic factors for osteosarcoma (OS) aids in the selection of patients who require more aggressive management. XB130 is a newly characterized adaptor protein that was reported to be to be a prognostic factor of certain tumor types. However, the association between XB130 expression and the prognosis of OS remains unknown. In the present study, we investigated the association between XB130 expression and clinicopathologic features and prognosis in patients suffering osteosarcoma, and further investigated its potential role on OS cells in vitro and vivo. A retrospective immunohistochemical study of XB130 was performed on archival formalin-fixed paraffin-embedded specimens from 60 pairs of osteosarcoma and noncancerous bone tissues, and compared the expression of XB130 with clinicopathological parameters. We then investigate the effect of XB130 silencing on invasion in vitro and lung metastasis in vivo of the human osteosarcoma cell line. Immunohistochemical assays revealed that XB130 expression in osteosarcoma tissues was significantly higher than that in corresponding noncancerous bone tissues (P=0.001). In addition, high XB130 expression more frequently occurred in osteosarcoma tissues with advanced clinical stage (P=0.002) and positive distant metastasis (P=0.001). Moreover, osteosarcoma patients with high XB130 expression had significantly shorter overall survival and disease-free survival (both P<0.001) when compared with patients with the low expression of XB130. The univariate analysis and multivariate analysis shown that high XB130 expression and distant metastasis were the independent poor prognostic factor. We showed that XB130 depletion by RNA interference inhibited invasion of XB130-rich U2OS cells in vitro and lung metastasis in vivo. This is the first study to reveal that XB130 overexpression may be related to the prediction of metastasis potency and poor prognosis for osteosarcoma patients, suggesting that XB130 may serve as a prognostic marker for the optimization of clinical treatments. Furthermore, XB130 is the potential molecular target for osteosarcoma therapy.
Subjects
Pathology & Lab MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 23 Jan 2018
Reduced expression level of miR-205 predicts poor prognosis in osteosarcoma
Research article · 30 Apr 2019
Paclitaxel induces apoptosis in osteosarcoma via promoting the production of reactive oxygen species and inhibiting the expression of cyclooxygenase-2
Research article · 24 Jan 2018
Expression and functions of microRNA-139 in osteosarcoma
Article · 2015
Total alkaloids in Dipsacus asperoides and their effects on proliferation of osteosarcoma SaOS-2 cell lines and gene expression of VEGF.
More from this journal
The newest in Journal of Clinical & Experimental Pathology.
Research article · 24 Feb 2025
Combining Urinary Biomarker Panels and Machine Learning For Earlier Detection of Pancreatic Cancer
Research article · 3 Feb 2025
Outbreak of Crimean Congo Haemorrhagic Fever in Northern Senegal in 2022
Review article · 16 Jan 2025
Recent Updates on Huntington Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Pathology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Xiaohui Wang”
- BylineArticles whose byline prints “Hai Huang”
- BylineArticles whose byline prints “Fengyun Hao”
- BylineArticles whose byline prints “Yu Li”
- BylineArticles whose byline prints “Lin Zhang”
